Showing results (151-160 of 220) with videos related to
Sort By:
Pageof 22
European Urology|February 27, 2017
Changing Current Practice in Urology: Improving Guideline Development and Implementation Through Stakeholder EngagementSara J MacLennan, Steven MacLennan, Axel Bex, et al.European Urology|December 5, 2016
Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses DisagreeRichard J Sylvester, Steven E Canfield, Thomas B L Lam, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 13, 2023
Morbidity of elective surgery for localized renal masses among elderly patients: A contemporary multicenter studyLeonardo D Borregales, Alessio Pecoraro, Eduard Roussel, et al.European Urology|February 18, 2015
Long-term Efficacy and Safety of Enzalutamide Monotherapy in Hormone-naïve Prostate Cancer: 1- and 2-Year Open-label Follow-up ResultsBertrand Tombal, Michael Borre, Per Rathenborg, et al.European Journal of Radiology|May 16, 2026
Use of Artificial Intelligence in prostate MRI: A rapid scoping review highlighting limited evidence in screening contextDeependra Singh, Juan Pablo Salazar Gutiérrez, Olivier Rouviere, et al.Clinical Genitourinary Cancer|December 15, 2017
Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic SettingAnnelies Verbiest, Gabrielle Couchy, Sylvie Job, et al.European Urology|February 22, 2018
Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete MetastasectomyAnnelies Verbiest, Gabrielle Couchy, Sylvie Job, et al.European Journal of Cancer (Oxford, England : 1990)|May 14, 2014
Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunitiesMarieke van Leeuwen, Fabio Efficace, Sophie D Fosså, et al.Clinical Genitourinary Cancer|August 7, 2021
Molecular Subtypes and Gene Expression Signatures as Prognostic Features in Fully Resected Clear Cell Renal Cell Carcinoma: A Tailored Approach to Adjuvant TrialsEduard Roussel, Annelies Verbiest, Lisa Kinget, et al.European Urology|July 4, 2012
Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomyGiacomo Novara, Vincenzo Ficarra, Raymond C Rosen, et al.Pageof 22